rs61733890
Positions:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_002055.5(GFAP):c.957G>A(p.Arg319Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000812 in 1,613,236 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0046 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00041 ( 4 hom. )
Consequence
GFAP
NM_002055.5 synonymous
NM_002055.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.369
Genes affected
GFAP (HGNC:4235): (glial fibrillary acidic protein) This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 17-44911406-C-T is Benign according to our data. Variant chr17-44911406-C-T is described in ClinVar as [Benign]. Clinvar id is 323611.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-44911406-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.369 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00465 (708/152360) while in subpopulation AFR AF= 0.0167 (693/41594). AF 95% confidence interval is 0.0156. There are 7 homozygotes in gnomad4. There are 342 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 708 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GFAP | NM_002055.5 | c.957G>A | p.Arg319Arg | synonymous_variant | 6/9 | ENST00000588735.3 | NP_002046.1 | |
GFAP | NM_001363846.2 | c.957G>A | p.Arg319Arg | synonymous_variant | 6/10 | NP_001350775.1 | ||
GFAP | NM_001242376.3 | c.957G>A | p.Arg319Arg | synonymous_variant | 6/7 | NP_001229305.1 | ||
GFAP | NM_001131019.3 | c.957G>A | p.Arg319Arg | synonymous_variant | 6/8 | NP_001124491.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GFAP | ENST00000588735.3 | c.957G>A | p.Arg319Arg | synonymous_variant | 6/9 | 1 | NM_002055.5 | ENSP00000466598.2 |
Frequencies
GnomAD3 genomes AF: 0.00464 AC: 707AN: 152242Hom.: 7 Cov.: 32
GnomAD3 genomes
AF:
AC:
707
AN:
152242
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00107 AC: 269AN: 250648Hom.: 3 AF XY: 0.000848 AC XY: 115AN XY: 135542
GnomAD3 exomes
AF:
AC:
269
AN:
250648
Hom.:
AF XY:
AC XY:
115
AN XY:
135542
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000412 AC: 602AN: 1460876Hom.: 4 Cov.: 33 AF XY: 0.000376 AC XY: 273AN XY: 726672
GnomAD4 exome
AF:
AC:
602
AN:
1460876
Hom.:
Cov.:
33
AF XY:
AC XY:
273
AN XY:
726672
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00465 AC: 708AN: 152360Hom.: 7 Cov.: 32 AF XY: 0.00459 AC XY: 342AN XY: 74508
GnomAD4 genome
AF:
AC:
708
AN:
152360
Hom.:
Cov.:
32
AF XY:
AC XY:
342
AN XY:
74508
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Sep 07, 2017 | - - |
Alexander disease Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Sep 18, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at